Puma Biotechnology reported $41.42M in Gross Profit on Sales for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
TG Therapeutics TGTX:US 1.4M 743K
Alexion Pharmaceuticals ALXN:US $ 1511.1M 71.5M
Alnylam Pharmaceuticals ALNY:US $ 190.3M 35.75M
Amgen AMGN:US $ 4889M 478M
Array Technologies Inc ARRY:US 26.79M 17.07M
Biogen BIIB:US $ 2315.3M 99.4M
Biomarin Pharmaceutical BMRN:US $ 374.63M 8.77M
Bluebird Bio BLUE:US $ -7829000 18.34M
Daiichi Sankyo 4568:JP Y 178917M 37069M
Esperion Therapeutics ESPR:US $ 38.86M 32.66M
Exelixis EXEL:US $ 370.29M 113.26M
Gilead Sciences GILD:US $ 4827M 235M
Glaxosmithkline GSK:US $ 5573M 566M
Intercept Pharmaceuticals ICPT:US $ 95.96M 15.11M
MacroGenics MGNX:US 30.74M 13.87M
Moderna Inc MRNA:US 3.6B 1.86B
Novartis NOVN:VX 9.54B 679M
Pfizer PFE:US $ 11985M 1575M
Ptc Therapeutics PTCT:US $ 109.32M 0.48M
Puma Biotechnology PBYI:US $ 41.42M 27.2M
Regeneron Pharmaceuticals REGN:US $ 4444.8M 2224.1M
Sarepta Therapeutics SRPT:US $ 144.57M 19.99M
Seattle Genetics SGEN:US $ 310.39M 42.54M
Ultragenyx Pharmaceutical RARE:US $ 83.84M 10.37M
Vanda Pharmaceuticals VNDA:US $ 61.33M 4.69M
Vertex Pharmaceuticals VRTX:US $ 1565.4M 33.42M
YTE INCY:US $ 673.08M 92.18M